Literature DB >> 19336247

A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.

Z-X Xi1, H K Kleitz, X Deng, B Ladenheim, X-Q Peng, X Li, E L Gardner, E A Stein, J L Cadet.   

Abstract

Psychostimulant addicts often take high doses of drugs, and high doses of psychostimulants such as methamphetamine (METH) are neurotoxic to striatal dopamine (DA) terminals. Yet, the effects of high doses of METH on drug-seeking and drug-taking behavior have not been examined. In the present study, we found that single high doses of METH in rats (10-20 mg/kg) dose-dependently increased cocaine self-administration under fixed-ratio 2 (FR2) reinforcement conditions, while higher doses (40 mg/kgx1 or 10 mg/kg/2 hx4) caused high mortality among rats maintained on daily cocaine self-administration. The increased cocaine self-administration appeared to be a compensatory response to reduced cocaine reward after METH, because the same doses of METH caused a dose-dependent reduction both in "break-point" levels for cocaine self-administration under progressive-ratio reinforcement and in nucleus accumbens DA response to acute cocaine. Further, METH (10-20 mg/kg) produced large DA release (4000%-6000% over baseline), followed by a significant reduction in striatal DA and 3,4-dihydroxyphenylacetic acid (DOPAC) contents, but without significant changes in striatal DA transporter levels. These findings suggest that the present high doses of METH caused striatal DA depletion or hypofunction without severe damage in DA terminals, which may contribute to the increased cocaine-taking behavior observed in the present study. Provided that the present doses of METH may mimic METH overdose incidents in humans, the present findings suggest that METH-induced DA depletion or neurotoxicity may lead to an increase in subsequent drug-taking and drug-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336247      PMCID: PMC3737775          DOI: 10.1016/j.neuroscience.2009.03.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward.

Authors:  P J Fletcher; K M Korth; J W Chambers
Journal:  Psychopharmacology (Berl)       Date:  1999-12       Impact factor: 4.530

Review 2.  Neuroadaptations involved in amphetamine and cocaine addiction.

Authors:  F J White; P W Kalivas
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

Review 3.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

4.  Regional and subcellular compartmentation of the dopamine transporter and tyrosine hydroxylase in the rat ventral pallidum.

Authors:  Elisa Mengual; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2004-01-12       Impact factor: 3.215

5.  Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.

Authors:  R A Yokel; R A Wise
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

6.  Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.

Authors:  T Kita; M Takahashi; G C Wagner; K Kubo; T Nakashima
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-10       Impact factor: 5.067

7.  High impulsivity predicts the switch to compulsive cocaine-taking.

Authors:  David Belin; Adam C Mar; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  Science       Date:  2008-06-06       Impact factor: 47.728

8.  Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.

Authors:  X Cen; A Nitta; D Ibi; Y Zhao; M Niwa; K Taguchi; M Hamada; Y Ito; Y Ito; L Wang; T Nabeshima
Journal:  Mol Psychiatry       Date:  2008-01-15       Impact factor: 15.992

Review 9.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.

Authors:  Colin Davidson; Tong H Lee; Everett H Ellinwood
Journal:  Neurochem Int       Date:  2005-01-08       Impact factor: 4.297

View more
  23 in total

1.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

2.  Methamphetamine reversed maternal separation-induced decrease in nerve growth factor in the ventral hippocampus.

Authors:  J J Dimatelis; V A Russell; D J Stein; W M Daniels
Journal:  Metab Brain Dis       Date:  2014-01-11       Impact factor: 3.584

3.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

4.  Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection.

Authors:  Michael T McCoy; Subramaniam Jayanthi; Jacqueline A Wulu; Genevieve Beauvais; Bruce Ladenheim; Tracey A Martin; Irina N Krasnova; Amber B Hodges; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2011-01-13       Impact factor: 4.530

Review 5.  Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi; Michael T McCoy; Genevieve Beauvais; Ning Sheng Cai
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

6.  In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.

Authors:  Alison D Kreisler; Michael J Terranova; Sucharita S Somkuwar; Dvijen C Purohit; Shanshan Wang; Brian P Head; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2020-04-03       Impact factor: 3.270

Review 7.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

8.  Environmental enrichment reduces methamphetamine cue-induced reinstatement but does not alter methamphetamine reward or VMAT2 function.

Authors:  Rebecca S Hofford; Mahesh Darna; Carrie E Wilmouth; Linda P Dwoskin; Michael T Bardo
Journal:  Behav Brain Res       Date:  2014-05-10       Impact factor: 3.332

Review 9.  Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Authors:  B Jupp; J W Dalley
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

10.  Genome-wide profiling identifies a subset of methamphetamine (METH)-induced genes associated with METH-induced increased H4K5Ac binding in the rat striatum.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi; Michael T McCoy; Bruce Ladenheim; Fabienne Saint-Preux; Elin Lehrmann; Supriyo De; Kevin G Becker; Christie Brannock
Journal:  BMC Genomics       Date:  2013-08-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.